Literature DB >> 8109913

Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm.

W M Dunne1, E O Mason, S L Kaplan.   

Abstract

Using an equilibrium dialysis chamber, we evaluated the penetration of vancomycin, rifampin, or both through a staphylococcal biofilm to simulate treatment of an infected biomedical implant. A biofilm of ATCC 35984 (slime-positive Staphylococcus epidermidis; vancomycin MIC and MBC, 1 and 2 micrograms/ml, respectively; rifampin MIC and MBC, 0.00003 and 0.00025 micrograms/ml, respectively) was established on the inner aspect of the dialysis membrane (molecular mass exclusion, 6,000 kDa). Serum containing vancomycin (40 micrograms/ml), rifampin (20 micrograms/ml), or a combination of both was introduced into the inner chamber of the dialysis unit (in direct contact with the biofilm), and serum alone was added to the outer chamber. Rifampin and vancomycin concentrations in both chambers were determined over a 72-h period. In the absence of rifampin, the concentration of vancomycin in the outer chamber exceeded the MBC for the organism after 24 h, and the MBC increased to nearly 8.0 micrograms/ml by 72 h, demonstrating that therapeutic levels of vancomycin can penetrate a staphylococcal biofilm. However, viable bacteria were recovered from the biofilm after 72 h of treatment with no apparent increase in the MIC or MBC of vancomycin. Similarly, concentrations of rifampin exceeding the MBC were detected in the outer chamber after 24 h of treatment, but viable organisms were recovered from the biofilm after 72 h of treatment. In this case, the rifampin MBCs for surviving organisms increased from 0.00025 to > 128 micrograms/ml. The combination of agents prevented the development of resistance to rifampin, improved the perfusion of vancomycin through the biofilm, and decreased the penetration of rifampin but did not sterilize the membrane. These observations provide evidence that bactericidal levels of vancomycin, rifampin, or both can be attained at the surface of an infected implant. Despite this, sterilization of the biofilm was not accomplished after 72 h of treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8109913      PMCID: PMC192727          DOI: 10.1128/AAC.37.12.2522

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci.

Authors:  D S Davenport; R M Massanari; M A Pfaller; M J Bale; S A Streed; W J Hierholzer
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

2.  Cell surface characteristics of coagulase-negative staphylococci and their adherence to fluorinated poly(ethylenepropylene).

Authors:  A H Hogt; J Dankert; C E Hulstaert; J Feijen
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  Interference with granulocyte function by Staphylococcus epidermidis slime.

Authors:  G M Johnson; D A Lee; W E Regelmann; E D Gray; G Peters; P G Quie
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

4.  Influence of bacterial adherence to intravascular catheters on in-vitro antibiotic susceptibility.

Authors:  N K Sheth; T R Franson; P G Sohnle
Journal:  Lancet       Date:  1985-12-07       Impact factor: 79.321

5.  Staphylococcal adherence to polyvinyl chloride and heparin-bonded polyurethane catheters is species dependent and enhanced by fibronectin.

Authors:  P B Russell; J Kline; M C Yoder; R A Polin
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

6.  Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces.

Authors:  G D Christensen; W A Simpson; A L Bisno; E H Beachey
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

7.  Staphylococcus epidermidis adhesion to hydrophobic biomedical polymer is mediated by platelets.

Authors:  I W Wang; J M Anderson; R E Marchant
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

8.  Characterization of clinically significant strains of coagulase-negative staphylococci.

Authors:  G D Christensen; J T Parisi; A L Bisno; W A Simpson; E H Beachey
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

9.  Staphylococcal peritonitis in patients on continuous peritoneal dialysis.

Authors:  T E West; J J Walshe; C P Krol; D Amsterdam
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

10.  Pseudomonas aeruginosa biofilm as a diffusion barrier to piperacillin.

Authors:  B D Hoyle; J Alcantara; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

View more
  63 in total

Review 1.  Bacterial adhesion: seen any good biofilms lately?

Authors:  W Michael Dunne
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

2.  Targeted delivery of vancomycin to Staphylococcus epidermidis biofilms using a fibrinogen-derived peptide.

Authors:  Christopher M Hofmann; James M Anderson; Roger E Marchant
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

3.  Rapid diffusion of fluorescent tracers into Staphylococcus epidermidis biofilms visualized by time lapse microscopy.

Authors:  Suriani Abdul Rani; Betsey Pitts; Philip S Stewart
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

4.  Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry.

Authors:  Nuno Cerca; Silvia Martins; Filipe Cerca; Kimberly K Jefferson; Gerald B Pier; Rosário Oliveira; Joana Azeredo
Journal:  J Antimicrob Chemother       Date:  2005-06-24       Impact factor: 5.790

5.  A three-dimensional computer model of four hypothetical mechanisms protecting biofilms from antimicrobials.

Authors:  Jason D Chambless; Stephen M Hunt; Philip S Stewart
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

Review 6.  Staphylococcal biofilms.

Authors:  M Otto
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

7.  The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms.

Authors:  Riddhi Kharidia; Jun F Liang
Journal:  J Microbiol       Date:  2011-09-02       Impact factor: 3.422

8.  Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.

Authors:  Ben Knippenberg; Madhu Page-Sharp; Sam Salman; Ben Clark; John Dyer; Kevin T Batty; Timothy M E Davis; Laurens Manning
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

9.  Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents.

Authors:  M Souli; H Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

10.  Tetracycline rapidly reaches all the constituent cells of uropathogenic Escherichia coli biofilms.

Authors:  G Stone; P Wood; L Dixon; M Keyhan; A Matin
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.